N Engl J Med. 2018 Sep 13;379(11):1093. doi: 10.1056/NEJMc1808566.
Lung Cancer with a High Tumor Mutational Burden.
Comment in
- Lung Cancer with a High Tumor Mutational Burden. [N Engl J Med. 2018]
Comment on
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. [N Engl J Med. 2018]
- PMID:
- 30211492
- DOI:
- 10.1056/NEJMc1808566
- [Indexed for MEDLINE]
No hay comentarios:
Publicar un comentario